NAD+ Metabolism

NAD+ Biosynthesis Pathways Explained

Written by ReCellence™ Editorial Team, Health Content SpecialistsReviewed by Medical Review Board, MD, PhDLast reviewed: March 8, 2026

Medical Disclaimer: This content is for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before making any health-related decisions. If you are experiencing a medical emergency, call your local emergency services immediately.

What This Page Explains

Cells synthesize NAD+ through three distinct pathways, each utilizing different precursors. Understanding these pathways is essential for evaluating NAD+-boosting strategies.

Stop Blaming Aging. Start Fixing the Real Problem.

Your genes aren't your destiny. But your mitochondria might be. Here's a science-backed approach to cellular energy.

Detailed Evidence

The three NAD+ biosynthesis pathways are: (1) De novo pathway — converts dietary tryptophan to NAD+ through an 8-step process via the kynurenine pathway; (2) Preiss-Handler pathway — converts niacin (nicotinic acid) to NAD+ through NAPRT and NMNAT enzymes; (3) Salvage pathway — recycles nicotinamide back to NAD+ via NAMPT (the rate-limiting step) and NMNAT. NMN and NR enter primarily through the salvage pathway.

Evidence Hierarchy

Strongest

Systematic Reviews & Meta-Analyses

Multiple high-quality trials combined

Strong

Randomized Controlled Trials (RCTs)

Gold standard for treatment efficacy

Moderate

Observational Studies

Can show associations, not causation

Limited

Case Reports & Expert Opinion

Hypothesis-generating only

Weakest

Preclinical (Lab/Animal) Studies

Should NOT be extrapolated to humans

How to Give Your Body's 37 Trillion Cells a Fighting Chance

Every cell in your body depends on mitochondria for energy. Support them with the nutrients research says they actually need.

Study Quality Indicators

Higher Quality Indicators

  • Large sample size (hundreds to thousands)
  • Randomized and blinded design
  • Placebo-controlled comparison
  • Published in peer-reviewed journals
  • Replicated in multiple studies
  • Registered trial protocol before starting

Lower Quality Indicators

  • Small sample size (under 100)
  • No control group or blinding
  • Manufacturer-funded with conflicts
  • Only animal/cell studies
  • Never replicated
  • Published in predatory journals

Important Limitations

  • • Supplement research often has methodological limitations
  • • Results from one study may not generalize to all people
  • • Marketing claims often exceed what research supports
  • • Absence of evidence is not evidence of absence
  • • Individual response to supplements varies widely

Quick Answers

Q1.

What are the three NAD+ biosynthesis pathways?

The de novo pathway (from tryptophan), the Preiss-Handler pathway (from niacin/nicotinic acid), and the salvage pathway (recycling nicotinamide).

Q2.

What is NAMPT and why is it important?

NAMPT is the rate-limiting enzyme of the salvage pathway that converts nicotinamide to NMN; it accounts for ~85% of NAD+ production and declines with age.

Q3.

What is the NAD+ salvage pathway?

It recycles nicotinamide (released when NAD+ is consumed by sirtuins/PARPs/CD38) back into NAD+ via NAMPT and NMNAT enzymes.

Q4.

How does the de novo pathway produce NAD+?

It converts dietary tryptophan to NAD+ through an 8-step process via the kynurenine pathway, contributing roughly 10–15% of NAD+ in most tissues.

Q5.

What is the Preiss-Handler pathway?

A three-step pathway that converts dietary niacin (nicotinic acid) to NAD+ via NAPRT and NMNAT enzymes.

Q6.

How does NR enter the NAD+ pathway?

Nicotinamide riboside (NR) is phosphorylated by NRK1/2 to NMN, then converted to NAD+ — bypassing the NAMPT bottleneck of the salvage pathway.

Q7.

How does NMN enter the NAD+ pathway?

Nicotinamide mononucleotide (NMN) is converted directly to NAD+ by NMNAT enzymes; a proposed SLC12A8 transporter may enable gut uptake, though debate continues.

Q8.

Which pathway is most important for NAD+ maintenance?

The salvage pathway is dominant, generating ~85% of NAD+, making NAMPT activity central to maintaining cellular NAD+.

Q9.

What regulates NAD+ biosynthesis?

NAMPT expression is circadian-regulated (CLOCK:BMAL1), creating daily NAD+ oscillations; NAD+ availability also feeds back through sirtuins.

Q10.

Can NAD+ biosynthesis be enhanced?

Yes — supplying precursors (NR, NMN, niacin) and supporting NAMPT activity can raise cellular NAD+, as shown in human trials.

Q11.

What is the role of NMNAT enzymes?

Three NMNAT isoforms perform the final NAD+ synthesis step in different compartments (nucleus, cytoplasm, mitochondria), enabling compartment-specific NAD+ pools.

Q12.

How does tryptophan contribute to NAD+?

Tryptophan feeds the de novo pathway via kynurenine, but inflammation can divert it away from NAD+ synthesis toward other metabolites.

Q13.

What happens when NAD+ biosynthesis fails?

Severe failure depletes NAD+, impairing energy production and DNA repair; extreme deficiency (as in pellagra) can be fatal.

Q14.

Do different tissues prefer different NAD+ pathways?

Yes — tissue enzyme profiles determine pathway preference; e.g., the liver relies heavily on salvage, while some immune cells use more de novo synthesis.

Q15.

Is NAD+ biosynthesis circadian-regulated?

Yes — NAMPT is controlled by the circadian clock, so NAD+ levels naturally rise and fall over 24 hours, linking metabolism to the sleep-wake cycle.

Key Research Facts

1

The NAD+ salvage pathway via NAMPT accounts for approximately 85% of total cellular NAD+ production.

Strong Evidence

Imai SI & Guarente L, Trends Cell Biol — doi:10.1016/j.tcb.2014.04.002

2

NAMPT is the rate-limiting enzyme of the salvage pathway, and its expression declines with age.

Strong Evidence

Revollo JR et al., J Biol Chem — doi:10.1074/jbc.M408168200

3

Three distinct NMNAT isoforms provide compartment-specific NAD+ synthesis in the nucleus, cytoplasm, and mitochondria.

Strong Evidence

Berger F et al., Trends Biochem Sci — doi:10.1016/j.tibs.2004.08.008

4

NR kinases (NRK1/2) provide an alternative salvage pathway entry point that bypasses the NAMPT bottleneck.

Strong Evidence

Bieganowski P & Brenner C, Cell — doi:10.1016/j.cell.2004.03.016

5

The de novo pathway from tryptophan requires 8 enzymatic steps and contributes ~10–15% of NAD+ in most tissues.

Strong Evidence

Katsyuba E et al., Nat Metab — doi:10.1038/s42255-019-0161-5

6

NAMPT expression is directly regulated by the circadian clock (CLOCK:BMAL1), creating 24-hour NAD+ oscillations.

Strong Evidence

Nakahata Y et al., Science — doi:10.1126/science.1170803

7

The SLC12A8 transporter may enable direct cellular NMN uptake in the gut, though this finding remains debated.

Moderate Evidence

Grozio A et al., Nat Metab — doi:10.1038/s42255-018-0009-4

8

Different tissues show distinct preferences for NAD+ biosynthetic pathways based on enzyme expression profiles.

Strong Evidence

Liu L et al., Cell Metab — doi:10.1016/j.cmet.2018.03.018

9

Inflammation diverts tryptophan toward kynurenine metabolites rather than NAD+, reducing de novo synthesis efficiency.

Strong Evidence

Katsyuba E et al., Nat Metab — doi:10.1038/s42255-019-0161-5

10

The Preiss-Handler pathway was first described in 1958 and converts dietary niacin to NAD+ in three enzymatic steps.

Strong Evidence

Preiss J & Handler P, J Biol Chem — doi:10.1016/S0021-9258(18)65730-X

Continue Your Research

Explore related topics and take the next step in your cellular health journey.

Citations & External Resources

Review

Annual Review of Nutrition — NAD+ biosynthetic pathways

Review

J Biol Chem — NAMPT as rate-limiting enzyme

Review

Nature Chemical Biology — NAD+ de novo synthesis

Review

Cell Metabolism — NAD+ precursor metabolism

Review

NIH — Tryptophan to NAD+ pathway

A Remarkable Discovery About Aging Cells (And What It Means For You)

Scientists now know that clearing 'zombie cells' can dramatically improve how your body produces energy. Here's the breakthrough.

Related Reading

References (3)

Written by

ReCellence™ Editorial Team

Health Content Specialists

Medically reviewed by

Medical Review Board

MD, PhD

Last updated: March 8, 2026

Last medical review: March 8, 2026